Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$173M |
| 2 |
Amcor
AMCR
|
+$138M |
| 3 |
Microsoft
MSFT
|
+$99.3M |
| 4 |
Amazon
AMZN
|
+$97.5M |
| 5 |
Intel
INTC
|
+$96.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$126M |
| 2 |
Alexandria Real Estate Equities
ARE
|
+$123M |
| 3 |
CHL
China Mobile Limited
CHL
|
+$58.6M |
| 4 |
IDTI
Integrated Device Technology I
IDTI
|
+$45.7M |
| 5 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$44.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.86% |
| 2 | Financials | 14.49% |
| 3 | Healthcare | 12.78% |
| 4 | Industrials | 10.5% |
| 5 | Consumer Discretionary | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
926
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $27.6M | 0.02% |
1,145,830
-285,905
| -20% | -$7.25M |
|
927
NetEase
NTES
$85.4B
| $27.6M | 0.02% |
538,720
+10,195
| +2% | +$541K |
|
928
Bankunited
BKU
$3.34B
| $27.6M | 0.02% |
816,529
+4,565
| +0.6% | +$157K |
|
929
Cleveland-Cliffs
CLF
$7.13B
| $27.4M | 0.02% |
2,571,884
-129,733
| -5% | -$1.28M |
|
930
Integra LifeSciences
IART
$1.33B
| $27.3M | 0.02% |
489,590
+13,192
| +3% | +$679K |
|
931
Kennametal
KMT
$2.41B
| $27.2M | 0.02% |
735,979
-164
| -0% | -$5.95K |
|
932
FTI Consulting
FCN
$4.17B
| $27.2M | 0.02% |
324,177
-6,196
| -2% | -$509K |
|
933
Armstrong World Industries
AWI
$7.75B
| $27.1M | 0.02% |
278,669
-21,343
| -7% | -$1.91M |
|
934
HEICO Corp
HEI
$50.9B
| $27.1M | 0.02% |
202,367
+10,068
| +5% | +$1.12M |
|
935
Empire State Realty Trust
ESRT
$802M
| $27.1M | 0.02% |
1,827,745
+1,219,607
| +201% | +$18.9M |
|
936
Pinnacle Financial Partners Inc
PNFP
$15.8B
| $27.1M | 0.02% |
470,900
+18,372
| +4% | +$1.03M |
|
937
ICU Medical
ICUI
$4.56B
| $27.1M | 0.02% |
107,444
+5,197
| +5% | +$1.2M |
|
938
Knight Transportation
KNX
$11.2B
| $27M | 0.02% |
822,458
+22,124
| +3% | +$706K |
|
|
SAVE
939
DELISTED
Spirit Airlines, Inc.
SAVE
| $27M | 0.02% |
565,166
-54,801
| -9% | -$2.79M |
|
|
BPMC
940
DELISTED
Blueprint Medicines
BPMC
| $27M | 0.02% |
285,873
+40,225
| +16% | +$3.32M |
|
941
Under Armour Class C
UA
$2.42B
| $26.9M | 0.02% |
1,213,770
+48,509
| +4% | +$1.01M |
|
942
Entegris
ENTG
$22B
| $26.9M | 0.02% |
720,370
-297,762
| -29% | -$11.3M |
|
943
Jabil
JBL
$35.3B
| $26.9M | 0.02% |
850,455
+22,183
| +3% | +$637K |
|
944
Brunswick
BC
$5.21B
| $26.8M | 0.02% |
584,434
+18,064
| +3% | +$872K |
|
|
AAN.A
945
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $26.8M | 0.02% |
436,582
+4,967
| +1% | +$305K |
|
|
PRSP
946
DELISTED
Perspecta Inc. Common Stock
PRSP
| $26.8M | 0.02% |
1,143,625
+44,332
| +4% | +$996K |
|
947
Nektar Therapeutics
NKTR
$2.53B
| $26.7M | 0.02% |
50,044
+1,834
| +4% | +$920K |
|
|
HI
948
DELISTED
Hillenbrand
HI
| $26.7M | 0.02% |
673,738
-16,372
| -2% | -$658K |
|
949
Acuity Brands
AYI
$10.6B
| $26.6M | 0.02% |
192,934
+6,500
| +3% | +$894K |
|
950
UFP Industries
UFPI
$5.01B
| $26.6M | 0.02% |
697,969
-3,543
| -0.5% | -$123K |
|
Similar funds
Charles Schwab's Q2 2019 Portfolio in Review
As of Q2 2019, Charles Schwab held 3,341 positions worth $164B, up 5.3% from $156B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Charles Schwab's Q2 2019 filing shows 147 new, 2,302 increased, 628 reduced and 129 closed positions. Its largest new stake was Dow Inc: 3,280,629 shares worth $162M. The largest sale was DuPont de Nemours, an estimated $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2019 buy was Dow Inc: 3,280,629 shares worth $162M.
- Charles Schwab added most to Microsoft in Q2 2019, an estimated $99.3M increase.
- Charles Schwab's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $126M.
- Charles Schwab fully exited China Mobile Limited in Q2 2019, selling an estimated $58.6M.
- Charles Schwab's ten largest holdings make up 15% of its $164B portfolio in Q2 2019.
- Charles Schwab opened 147 new positions and closed 129 in Q2 2019.
- Charles Schwab's portfolio value rose 5.3% quarter-over-quarter to $164B.
Based on Charles Schwab's 13F filing for Q2 2019, filed 9 Aug 2019.